Oncotarget

Vol 10, No 2

January 4, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 2 of Oncotarget features Supplementary Figure 4, "Using principal component analysis, distributions of subtypes in the Burstein et al. training set and our data set are shown," by Ding, et al.

Table of Contents

Editorial

The extended 4-year follow-up results of the ELOQUENT-2 trial

The extended 4-year follow-up results of the ELOQUENT-2 trial

https://doi.org/10.18632/oncotarget.26527

Maria Gavriatopoulou, Evangelos Terpos,  and Meletios Athanasios Dimopoulos
82-83
PDF  |  Order a Reprint

We shall overcome (drug resistance) some day

We shall overcome (drug resistance) some day

https://doi.org/10.18632/oncotarget.26550

Geeta G. Sharma,  and Luca Mologni
84-85
PDF  |  Order a Reprint

AI for medical use

AI for medical use

https://doi.org/10.18632/oncotarget.26556

Masamitsu Konno,  and Hideshi Ishii
86-87
PDF  |  Order a Reprint

Research Papers

Association between thyroid function and diabetic nephropathy in euthyroid subjects with type 2 diabetes mellitus: a cross-sectional study in China

Association between thyroid function and diabetic nephropathy in euthyroid subjects with type 2 diabetes mellitus: a cross-sectional study in China

https://doi.org/10.18632/oncotarget.26265

Jian Wang, Huiqin Li, Mingjuan Tan, Gu Gao, Ying Zhang, Bo Ding, Xiaofei Su, Xiaocen Kong,  and Jianhua Ma
88-97
Abstract  |  PDF  |  HTML  |  Order a Reprint

Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: putative role of decreased TIMP-1 and TIMP-2

Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: putative role of decreased TIMP-1 and TIMP-2

https://doi.org/10.18632/oncotarget.26414

J. Dinesh Kumar, Iman Aolymat, Laszlo Tiszlavicz, Zita Reisz, Hanan M. Garalla, Rob Beynon, Deborah Simpson, Graham J. Dockray,  and Andrea Varro
98-112
Abstract  |  PDF  |  HTML  |  Order a Reprint

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies

https://doi.org/10.18632/oncotarget.26451

Ashleigh C. McEvoy, Michelle R. Pereira, Anna Reid, Robert Pearce, Lester Cowell, Zeyad Al-Ogaili, Muhammad A. Khattak, Michael Millward, Tarek M. Meniawy, Elin S. Gray,  and Melanie Ziman
113-122
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

RASSF1C regulates miR-33a and EMT marker gene expression in lung cancer cells

RASSF1C regulates miR-33a and EMT marker gene expression in lung cancer cells

https://doi.org/10.18632/oncotarget.26498

Yousef G. Amaar,  and Mark E. Reeves
123-132
Abstract  |  PDF  |  HTML  |  Order a Reprint

Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility

Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility

https://doi.org/10.18632/oncotarget.26512

Diva S. Whalen, Sarrah E. Widatalla, Olga Y. Korolkova, Gladys S. Nangami, Heather K. Beasley, Stephen D. Williams, Carlos Virgous, Brian D. Lehmann, Josiah Ochieng,  and Amos M. Sakwe
133-151
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers

Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers

https://doi.org/10.18632/oncotarget.26520

Jyoti Roy, Miranda Kaake,  and Philip S. Low
152-160
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Low-dose eribulin reduces lung metastasis of osteosarcoma in vitro and in vivo

Low-dose eribulin reduces lung metastasis of osteosarcoma in vitro and in vivo

https://doi.org/10.18632/oncotarget.26536

Kenta Watanabe, Yoshihiro Yui, Satoru Sasagawa, Kayo Suzuki, Masahiko Kanamori, Taketoshi Yasuda,  and Tomoatsu Kimura
161-174
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Photo-immune therapy with liposomally formulated phospholipid-conjugated indocyanine green induces specific antitumor responses with heat shock protein-70 expression in a glioblastoma model

Photo-immune therapy with liposomally formulated phospholipid-conjugated indocyanine green induces specific antitumor responses with heat shock protein-70 expression in a glioblastoma model

https://doi.org/10.18632/oncotarget.26544

Sayaka Shibata, Natsuki Shinozaki, Akiko Suganami, Shiro Ikegami, Yuki Kinoshita, Ryozo Hasegawa, Hirata Kentaro, Yoshiharu Okamoto, Ichio Aoki, Yutaka Tamura,  and Yasuo Iwadate
175-183
Abstract  |  PDF  |  HTML  |  Order a Reprint

Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion

Failures in preclinical and clinical trials of c-Met inhibitors: evaluation of pathway activity as a promising selection criterion

https://doi.org/10.18632/oncotarget.26546

Veronica S. Hughes,  and Dietmar W. Siemann
184-197
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity

https://doi.org/10.18632/oncotarget.26559

Yuan Chun Ding, Linda Steele, Charles Warden, Sharon Wilczynski, Joanne Mortimer, Yuan Yuan,  and Susan L. Neuhausen
198-208
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Meta-Analysis

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis

Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis

https://doi.org/10.18632/oncotarget.26541

Luigi Cavanna, Chiara Citterio,  and Elena Orlandi
209-215
Abstract  |  PDF  |  HTML  |  Order a Reprint

Reviews

Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection

Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection

https://doi.org/10.18632/oncotarget.26537

Muntasir Billah, Anisyah Ridiandries, Usaid Allahwala, Harshini Mudaliar, Anthony Dona, Stephen Hunyor, Levon M. Khachigian,  and Ravinay Bhindi
216-244
Abstract  |  PDF  |  HTML  |  Order a Reprint

Case Reports

ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma

ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma

https://doi.org/10.18632/oncotarget.26521

Eric I. Marks, Sahithi Pamarthy, Don Dizon, Ari Birnbaum, Evgeny Yakirevich, Howard Safran,  and Benedito A. Carneiro
245-251
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors

Correction: Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors

https://doi.org/10.18632/oncotarget.26575

Xiaoliang Zhao, Xiaohua Wen, Wei Wei, Yulong Chen, Jianquan Zhu,  and Changli Wang
252-252
Correction  |  PDF

Correction: Incidence and risk of regorafenib-induced hepatotoxicity

Correction: Incidence and risk of regorafenib-induced hepatotoxicity

https://doi.org/10.18632/oncotarget.26576

Bin Zhao,  and Hong Zhao
253-253
Correction  |  PDF

Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib

Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib

https://doi.org/10.18632/oncotarget.26577

Bin Zhao,  and Hong Zhao
254-254
Correction  |  PDF


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC